Helland A - Search Results

1

Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.

Haakensen VD, Lingjaerde OC, Lüders T, Riis M, Prat A, Troester MA, Holmen MM, Frantzen JO, Romundstad L, Navjord D, Bukholm IK, Johannesen TB, Perou CM, Ursin G, Kristensen VN, Børresen-Dale AL, Helland A. Haakensen VD, et al. Among authors: helland a. BMC Med Genomics. 2011 Nov 1;4:77. doi: 10.1186/1755-8794-4-77. BMC Med Genomics. 2011. PMID: 22044755 Free PMC article.

2

Microsatellite instability in cervical and endometrial carcinomas.

Helland A, Børresen-Dale AL, Peltomäki P, Hektoen M, Kristensen GB, Nesland JM, de la Chapelle A, Lothe RA. Helland A, et al. Int J Cancer. 1997 Mar 4;70(5):499-501. doi: 10.1002/(sici)1097-0215(19970304)70:5<499::aid-ijc1>3.0.co;2-t. Int J Cancer. 1997. PMID: 9052745

3

An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women.

Helland A, Olsen AO, Gjøen K, Akselsen HE, Sauer T, Magnus P, Børresen-Dale AL, Rønningen KS. Helland A, et al. Int J Cancer. 1998 Mar 30;76(1):19-24. doi: 10.1002/(sici)1097-0215(19980330)76:1<19::aid-ijc4>3.0.co;2-0. Int J Cancer. 1998. PMID: 9533756

4

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Børresen-Dale Al. Helland A, et al. Br J Cancer. 1998 Jul;78(1):69-72. doi: 10.1038/bjc.1998.444. Br J Cancer. 1998. PMID: 9662253 Free PMC article.

5

Allelic imbalance at chromosome region 11q23 in cervical carcinomas.

Skomedal H, Helland A, Kristensen GB, Holm R, Børresen-Dale AL. Skomedal H, et al. Among authors: helland a. Eur J Cancer. 1999 Apr;35(4):659-63. doi: 10.1016/s0959-8049(98)00413-4. Eur J Cancer. 1999. PMID: 10492643

6

p53 polymorphism and cervical cancer.

Helland A, Børresen-Dale AL. Helland A, et al. Lancet. 1999 Oct 30;354(9189):1561-2. doi: 10.1016/S0140-6736(05)76596-X. Lancet. 1999. PMID: 10551531 No abstract available.

7

Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival.

Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA. Helland A, et al. Int J Cancer. 2000 Oct 15;88(2):217-22. doi: 10.1002/1097-0215(20001015)88:2<217::aid-ijc11>3.0.co;2-i. Int J Cancer. 2000. PMID: 11004671

8

Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.

Dai H, Holm R, Kristensen GB, Abeler VM, Børresen-Dale AL, Helland A. Dai H, et al. Among authors: helland a. Anal Cell Pathol. 2001;23(2):45-9. doi: 10.1155/2001/521873. Anal Cell Pathol. 2001. PMID: 11904459 Free PMC article.

9

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.

Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A. Wang Y, et al. Among authors: helland a. Hum Mutat. 2004 Jul;24(1):21-34. doi: 10.1002/humu.20055. Hum Mutat. 2004. PMID: 15221786

10

PIK3CA mutations in advanced ovarian carcinomas.

Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL. Wang Y, et al. Among authors: helland a. Hum Mutat. 2005 Mar;25(3):322. doi: 10.1002/humu.9316. Hum Mutat. 2005. PMID: 15712344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters